Since our data also demonstrated an increased plasma sNRP1 level 4-h post insulin-induced hypoglycaemia, it is highly likely that glycemic control-mediated improvement of severity in COVID-19 patients is associated with elevated sNRP1. Here, INS is linked to COVID-19.